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Abstract: Testicular germ cell cancer develops from pre-malignant intratubular germ cell neoplasia, 25 
unclassified cells that are believed to arise from failure of normal maturation of fetal germ cells from 26 
gonocytes (OCT4+/ MAGEA4-) into pre-spermatogonia (OCT4-/MAGEA4+). Intratubular germ cell neoplasia 27 
cell subpopulations based on stage of germ cell differentiation have been described, however the importance 28 
of these subpopulations in terms of invasive potential has not been reported. We hypothesised that cells 29 
expressing an immature (OCT4+/ MAGEA4-) germ cell profile would exhibit an increased proliferation rate 30 
compared to those with a mature profile (OCT4+/ MAGEA4+). Therefore, we performed triple 31 
immunofluorescence and stereology to quantify the different intratubular germ cell neoplasia cell 32 
subpopulations, based on expression of germ cell (OCT4, PLAP, AP2γ, MAGEA4, VASA) and proliferation 33 
(Ki67) markers, in testis sections from patients with pre-invasive disease, seminoma and non-seminoma. We 34 
compared these subpopulations with normal human fetal testis and with seminoma cells. Heterogeneity of 35 
protein expression was demonstrated in intratubular germ cell neoplasia cells with respect to gonocyte and 36 
spermatogonial markers. It included an embryonic/fetal germ cell subpopulation lacking expression of the 37 
definitive intratubular germ cell neoplasia marker OCT4, that did not correspond to a physiological (fetal) 38 
germ cell subpopulation. OCT4+/MAGEA4- cells showed a significantly increased rate of proliferation 39 
compared with the OCT4+/MAGEA4+ population (12.8 v 3.4%, p<0.0001) irrespective of histological tumour 40 
type, reflected in the predominance of OCT4+/MAGEA4- cells in the invasive tumour component. 41 
Surprisingly, OCT4+/MAGEA4- cells in patients with pre-invasive disease showed significantly higher 42 
proliferation compared to those with seminoma or non-seminoma (18.1 v 10.2 v 7.2%, p<0.05 respectively). 43 
In conclusion, this study has demonstrated that OCT4+/MAGEA4- cells are the most frequent and most 44 
proliferative cell population in tubules containing intratubular germ cell neoplasia, which appears to be an 45 
important factor in determining invasive potential of intratubular germ cell neoplasia to seminomas.  46 
 47 
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Introduction 52 
Testicular germ cell cancer is the most common malignancy in young men and the incidence of these tumours 53 
is increasing worldwide [1,2]. The tumours are classified as seminoma or non-seminoma with a distinct cell of 54 
origin and pathogenesis compared with spermatocytic seminoma of late adulthood [1]. These tumours result 55 
from transformation, usually in young adulthood, of pre-invasive intratubular germ cell neoplasia (also known 56 
as carcinoma in situ) cells that arise during fetal life [3,4]. Intratubular germ cell neoplasia cells are believed to 57 
be germ cells that have failed to undergo normal maturation during fetal or early postnatal life.  58 
 59 
In humans, during fetal life, primordial germ cells migrate into the developing gonad at around 5 weeks of 60 
gestation and become gonocytes [5]. These cells express proteins associated with pluripotency (e.g. OCT4 and 61 
NANOG) [6,7] and a number of other embryonic markers (e.g. AP2γ and PLAP) [8,9]. During the remainder 62 
of fetal life and into the early postnatal period these cells begin to express germ cell specific proteins (e.g. 63 
VASA and MAGEA4) during their transition from gonocytes into spermatogonia and this is associated with a 64 
loss of the gonocyte protein markers [7]. This transition occurs in an asynchronous manner such that cells at 65 
different stages of development may be present in an individual seminiferous cord during this period and some 66 
of these cells may co-express both gonocyte and a spermatogonial markers [10].  67 
 68 
Intratubular germ cell neoplasia cells express many of the same proteins as gonocytes (e.g. OCT4, PLAP, 69 
AP2γ) and these are often used in conjunction with histological evaluation to diagnose the condition in 70 
testicular biopsies [11]. It is also recognised that intratubular germ cell neoplasia cells may express proteins 71 
indicative of spermatogonia (e.g. MAGEA4, VASA, TSPY) [3,12,13]. The clinical significance of the 72 
differing protein expression profiles amongst intratubular germ cell neoplasia cells is not known.  73 
 74 
Proliferation of pre-invasive cells is important for the development of an invasive tumour and proliferation has 75 
been shown to occur in intratubular germ cell neoplasia cells prior to the development of an invasive tumour 76 
[12]. However, proliferation in the different sub-populations of intratubular germ cell neoplasia cells, based on 77 
germ cell differentiation profile, has not previously been investigated. 78 
 79 
The aim of this study was to characterise the heterogeneous protein expression profiles of intratubular germ 80 
cell neoplasia cells using co-localisation of multiple proteins simultaneously and to compare this to the 81 
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expression profiles of normal germ cells in the human fetal testis. In addition we aimed to quantify the 82 
different intratubular germ cell neoplasia sub-populations associated with different testicular germ cell cancer 83 
histological types and to investigate whether the protein expression profile of intratubular germ cell neoplasia 84 
cells is related to proliferation of these cells and hence to their invasive potential.       85 
 86 
Materials and Methods 87 
Tissue collection 88 
Human intratubular germ cell neoplasia/testicular germ cell cancer tissue: Ethical approval was obtained for 89 
the use of archived human testicular tissue from the Pathology Departments at the Western General Hospital in 90 
Edinburgh (REC Reference number - 10/S1402/33) and Erasmus MC-University Medical Center, Rotterdam 91 
(Institutional review board - MEC 02.981 and CCR2041). Samples were randomly selected from the testicular 92 
germ cell tumour database and analysed by light microscopy for the presence of intratubular germ cell 93 
neoplasia cells. The diagnosis included pre-invasive disease (childhood, n=4; adulthood, n=7), seminoma 94 
(n=9) and non-seminoma (n=8). Patient details are described in Table 1. The specimens had been fixed in 95 
formalin for 24 hours. 96 
 97 
Human Fetal Testes: Human fetal testes were obtained following termination of pregnancy during 2nd 98 
trimester (14-19 weeks, n=5). Women gave consent in accordance with national guidelines, and ethical 99 
approval was obtained from the Local Research Ethics Committee (Reference number – LREC08/S1101/1). 100 
No terminations were due to fetal abnormalities. Gestational age was determined initially by ultrasound, 101 
followed by measurement of foot length. Testes were fixed for 2h in Bouins, transferred into 70% ethanol and 102 
then embedded in paraffin. Sections of 5m thickness were prepared. 103 
 104 
Immunohistochemistry 105 
Details of antibodies, dilutions and requirement for antigen retrieval are shown in Table 2. Sections were 106 
dewaxed in xylene, rehydrated in graded alcohols and washed in tap water. Antigen retrieval involved pressure 107 
cooking in 0.01M citrate (pH 6.0) buffer as described previously [14]. Sections were treated with 3% (v/v) 108 
H2O2 in methanol for 30 min and washed in water, followed by Tris-buffered saline (TBS, 0.05M Tris and 109 
0.85% NaCl, pH 7.6) for a further 5 min. Endogenous biotin was blocked using an avidin/biotin blocking kit 110 
(Vector Laboratories, Peterborough, UK), according to the manufacturers instructions. Sections were 111 
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incubated in appropriate normal serum (diluted 1:5 with TBS containing 5% (w/v) bovine serum albumin 112 
(BSA) (Sigma, Poole, Dorset, UK) for 30 min. Sections were incubated overnight with primary antibody 113 
diluted in serum at 4oC in a humidified chamber. Sections were washed in TBS (2x5min) and incubated for 30 114 
min with the appropriate biotinylated secondary antibody (swine anti-rabbit, rabbit anti-mouse; both Dako, 115 
Ely, UK or rabbit anti-goat; Vector Laboratories), diluted in normal serum. This was followed by two further 5 116 
min washes in TBS and incubation for 30 min with Streptavidin-HRP at 1:1000 (Dako), diluted in TBS.  117 
 118 
Visualisation was performed using 3,3-diaminobenzidine tetrahydrochloride (DAB) (Dako) and sections were 119 
counterstained with haematoxylin, dehydrated in graded alcohols, immersed in xylene and mounted in Pertex 120 
medium (CellPath, Hemel Hempstead, UK). For each experiment a negative control (primary antibody 121 
replaced with the appropriate normal serum) was included. Images were captured using an Olympus Provis 122 
microscope (Olympus, London, UK) and Canon DS126131 camera with Canon EOS image capture software 123 
(Canon, Woodhatch, Surrey, UK). 124 
 125 
Immunofluorescence 126 
Sections were initially treated as described for single staining as far as the primary antibody stage, with 127 
Phosphate Buffered Saline (PBS; Sigma) washes between each step. Antigen retrieval was required for all 128 
experiments. Details of antibodies, serum and visualisation method are listed in Table 2. 129 
 130 
Following overnight incubation with primary antibody in serum, sections were incubated with secondary 131 
antibody for 30 min, followed by fluorescently labelled Tyramide (1:50; Perkin Elmer, Cambridge, UK) in 132 
dilution buffer. For this and subsequent steps, the sections were kept in darkness. Sections were then 133 
microwaved in 0.01M citrate (pH 6.0) for 2.5 min and left to cool for 30 min, before being washed in water 134 
and PBS for 5 min. Sections were incubated for 30 min in serum. They were incubated with secondary 135 
antibody for 30 min, followed by the labelled Tyramide (1:50) using a different fluorescent label. After the 136 
second visualisation sections were microwaved again as described above and incubated with the third 137 
secondary antibody for 30 min, followed by the third labelled Tyramide (1:50). DAPI (Sigma) was applied to 138 
the sections at 1:1000 in PBS for 10 min and the slides were mounted using Permafluor (Immunotech, 139 
Marseille, France). Images were captured using an LSM 510 Confocal microscope (Carl Zeiss, Hertfordshire, 140 
UK). 141 
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 142 
Quantification of germ cell differentiation and proliferation 143 
Quantification of germ cell subpopulations and proliferation indices were performed for the triple-stained 144 
sections as previously described [10]. For each sample, a minimum of 10 randomly selected fields with tubules 145 
containing intratubular germ cell neoplasia were counted and included an average of 1000 cells per section.  146 
Images were obtained using an Axiovert 200M microscope with attached Axiocam HRc camera and 147 
Axiovision 4.6 software (all Carl Zeiss). All germ cells within each section were manually counted and 148 
quantified according to their protein expression profile and proliferation status by marking cells in layered 149 
images using Adobe Photoshop 7.0 (Adobe, San Jose, CA, USA). 150 
 151 
Statistics 152 
Statistical analysis was performed using Graphpad Prism 5 software (La Jolla, CA, USA). Groups were 153 
compared using Students t-test. Multiple groups were analysed using one-way analysis of variance (ANOVA). 154 
Statistical significance was set at P<0.05. 155 
 156 
Results 157 
In order to characterise the heterogeneity of expression of germ cell proteins in putative intratubular germ cell 158 
neoplasia cells we first compared the expression of a range of germ cell-specific proteins in testicular tissue 159 
from patients with testicular germ cell cancer (including tubules containing intratubular germ cell neoplasia 160 
cells and those with apparently normal spermatogenesis) with that of the normal human fetal testis.  161 
 162 
Expression of gonocyte markers in human fetal testis, intratubular germ cell neoplasia and 163 
spermatogonia 164 
OCT4, AP2γ and PLAP were expressed in germ cells (gonocytes) in the human fetal testis.  In sections from 165 
patients with testicular germ cell cancer these proteins were also expressed in intratubular germ cell neoplasia 166 
cells; however none of the proteins were expressed in spermatogonia in tubules that contained active 167 
spermatogenesis (Fig. 1A-I).  168 
 169 
Expression of spermatogonial markers in human fetal testis, intratubular germ cell neoplasia and 170 
spermatogonia 171 
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MAGEA4 and VASA were expressed in germ cells (pre-spermatogonia) in the human fetal testis. These 172 
proteins were also expressed in intratubular germ cell neoplasia cells. There was also expression of these 173 
proteins in germ cells (MAGEA4 in spermatogonia and early spermatocytes, VASA in all germ cells) of 174 
tubules that contained active spermatogenesis in patients with testicular germ cell cancer (Fig 1J-O). 175 
 176 
Co-expression of gonocyte and spermatogonial markers in intratubular germ cell neoplasia cells and 177 
normal testis 178 
For the identification of intratubular germ cell neoplasia cells and to attempt to distinguish these cells from 179 
normal germ cells, AP2γ and VASA co-expression was investigated (Fig 2). In tubules with normal-appearing 180 
spermatogenesis there was expression of VASA in the cytoplasm of germ cells, but no expression of AP2γ 181 
(Fig 2A). In tubules containing a mixture of germ cells characteristic of either intratubular germ cell neoplasia 182 
or normal spermatogonia the putative intratubular germ cell neoplasia cells (located on the basement 183 
membrane) were identified as AP2γ+/VASA-, whilst a small proportion of these cells were AP2γ+/VASA+ (Fig 184 
2B). AP2γ-/VASA+cells, located nearer the lumen were also identified in intratubular germ cell neoplasia 185 
tubules. These putative spermatocytes were also identified in tubules in which the majority of the cells were 186 
intratubular germ cell neoplasia cells (AP2γ+/VASA-; Fig 2C). Similar populations of germ cells were also 187 
identified within the human fetal testis, based on co-staining for OCT4 and VASA (Supp. Fig. 1; [7]).  188 
 189 
Heterogeneity of expression of ‘classical’ intratubular germ cell neoplasia markers in patients with 190 
testicular germ cell cancer 191 
In order to demonstrate the heterogeneity of expression of gonocyte proteins in intratubular germ cell 192 
neoplasia, co-localisation of OCT4, AP2γ and PLAP was undertaken. OCT4 and AP2γ were always co-193 
expressed and were localised to the nuclei of intratubular germ cell neoplasia cells (Supp. Fig. 2). A similar 194 
pattern of co-expression was demonstrated for OCT4 and PLAP, with co-expression of OCT4 (nuclear) and 195 
PLAP (cytoplasm +/- nuclear)  in the majority of cells (OCT4+/PLAP+) within these tubules, however there 196 
were also germ cells that were OCT4+/PLAP- (Fig. 3A). These two populations were also identified in the 197 
human fetal testis (Fig. 3B). However within the intratubular germ cell neoplasia containing tubules we also 198 
identified a rare population of cells that were OCT4-/PLAP+ (Fig. 3C), whilst this population of germ cells was 199 
not identified in any of the human fetal testis sections (Fig. 3B). 200 
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 201 
The expression of spermatogonial markers in putative intratubular germ cell neoplasia cells  202 
To further characterise the germ cells within intratubular germ cell neoplasia containing tubules that either did 203 
or did not express OCT4, triple immunofluorescence staining was undertaken for MAGEA4/VASA, OCT4 204 
and PLAP (Fig. 4). In tubules containing intratubular germ cell neoplasia cells, the majority of germ cells 205 
expressed nuclear OCT4 and most of these were co-stained with PLAP (cytoplasmic +/- nuclear). A small 206 
proportion of presumptive spermatocytes expressed VASA only (Fig. 4A). However there were infrequent 207 
germ cells which expressed VASA and PLAP, but which did not express OCT4 (Fig. 4A), suggesting that a 208 
proportion of the VASA expressing cells (VASA+/OCT4-) are not ‘normal’ spermatogonia/spermatocytes and 209 
may represent gonocytes that have downregulated OCT4 and begun to express VASA but retain PLAP 210 
expression (VASA+/OCT4-/PLAP+). Similar sub-populations were found when the co-expression of MAGEA4 211 
with OCT4 and PLAP was undertaken (Figure 4B). 212 
 213 
Quantification of intratubular germ cell neoplasia phenotypes depending on histological testicular germ 214 
cell cancer type 215 
The proportion of intratubular germ cell neoplasia cells (identified by expression of OCT4 and/or PLAP) with 216 
different expression profiles based on OCT4/PLAP/MAGEA4 co-staining was determined (Fig. 5). By far the 217 
most common phenotype was OCT4+/PLAP+/MAGEA4-, which was found in a significantly higher proportion 218 
(68%) of cells compared with the other phenotypes (Fig. 5; b versus a,c). A smaller proportion (7.7%) of 219 
intratubular germ cell neoplasia cells were OCT4+/PLAP-/MAGEA4-. Overall 82% of intratubular germ cell 220 
neoplasia cells expressed OCT4 with the remaining 18% of putative intratubular germ cell neoplasia cells 221 
expressing PLAP (but no detectable OCT4). In terms of spermatogonial markers, MAGEA4 expression was 222 
found in 6% of putative intratubular germ cell neoplasia cells (defined by expression of OCT4 and/or PLAP; 223 
Fig. 5) and this represented a significantly lower proportion of cells compared to those not expressing 224 
MAGEA4 (Fig 5; c versus a,b). There was a shift towards an increasing proportion of these MAGEA4+ cells 225 
from pre-invasive (child) to pre-invasive (adult) and seminoma, whilst very few putative intratubular germ cell 226 
neoplasia cells in non-seminoma expressed this protein profile, however the differences in expression were not 227 
significant (Supp. Fig. 3). 228 
 229 
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Proliferation of intratubular germ cell neoplasia cells according to germ cell expression profile and 230 
histological testicular germ cell cancer type  231 
In order to investigate whether the germ cell expression profile of the putative intratubular germ cell neoplasia 232 
cells might determine their proliferation rate, which might in turn affect their invasive potential, triple 233 
immunofluorescence for OCT4/MAGEA4/Ki67 was performed (Supp. Fig. 4). Overall, the proportion of 234 
proliferating (Ki67+/OCT4+) intratubular germ cell neoplasia cells was 8.1% (Fig. 6A). There was a shift 235 
towards increased proliferation in intratubular germ cell neoplasia cells from patients with pre-invasive disease 236 
compared with those with a seminoma or non-seminoma, but this was not statistically significant (Supp. Fig. 237 
5). However, when intratubular germ cell neoplasia (identified by expression of OCT4+) cell proliferation was 238 
analysed according to whether or not the cells also expressed MAGEA4, a significantly higher proliferation 239 
rate was found for the OCT4+/MAGEA4- population compared to OCT4+/MAGEA4+ intratubular germ cell 240 
neoplasia cells (12.8 v 3.4%, p<0.0001; Fig. 6B). Moreover, the significant difference in proliferation rate 241 
between the two intratubular germ cell neoplasia phenotypes was consistent when the same analysis was 242 
performed according to whether the intratubular germ cell neoplasia cells were from patients with pre-invasive 243 
disease (child or adult), seminoma or non-seminoma (Fig. 6C-F). Furthermore, when the proliferation rates in 244 
the two sub-populations of intratubular germ cell neoplasia cells (OCT4+/MAGEA4- or OCT4+/MAGEA4+) 245 
were compared according to the histology of the adjacent testicular germ cell cancer, there was a significantly 246 
higher proliferation rate in the OCT4+/MAGEA4- cells in pre-invasive disease compared with these cells in 247 
seminoma and non-seminoma (Fig. 7A); in contrast, there was no difference in the proportion of 248 
OCT4+/MAGEA4+ that were proliferating for the different tumour types (Fig. 7B). 249 
 250 
Proliferation of seminoma cells according to germ cell expression profile 251 
Given that the OCT4+/MAGEA4- population of intratubular germ cell neoplasia cells were more proliferative 252 
than the OCT4+/MAGEA4+ population, we investigated MAGEA4, OCT4 and PLAP expression in seminoma 253 
cells in order to determine whether this results in a predominance of OCT4+/MAGEA4- cells in the resulting 254 
tumours. Indeed we found that in the majority of intra-tubular seminoma cells MAGEA4 was not expressed 255 
and that the majority of cells were OCT4+/PLAP+/MAGEA4- (Fig. 8A). MAGEA4 positive cells were seen in 256 
tubules with normal appearance adjacent to areas of invasive seminoma (Fig. 8B), however MAGEA4 257 
expression was not seen in the invasive seminoma cells (Fig. 8C). The OCT4+/MAGEA4- seminoma cells 258 
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were highly proliferative, whilst a smaller proportion of OCT4+/MAGEA4- intratubular germ cell neoplasia 259 
cells were proliferative. In contrast MAGEA4 expressing cells were rarely proliferative (Supp. Fig. 6). 260 
 261 
Discussion 262 
The present study has characterised the heterogeneity of germ cell protein expression in the human testis based 263 
on co-expression of germ cell proteins involved in differentiation from gonocyte to pre-spermatogonia. We 264 
have demonstrated an infrequent population of cells within intratubular germ cell neoplasia containing tubules 265 
with an expression profile distinct from germ cells in the normal human fetal testis. We have also 266 
demonstrated that the most common sub-population in intratubular germ cell neoplasia containing tubules, 267 
which displays a ‘gonocyte’ expression profile (OCT4+/MAGEA4-), is associated with an increased 268 
proliferation rate compared to the subpopulation expressing a ‘pre-spermatogonial’ profile 269 
(OCT4+/MAGEA4+), and that this (OCT4+/MAGEA4-) population represents the true intratubular germ cell 270 
neoplasia cell and precursor for invasive seminoma and non-seminoma. The findings of the present study are 271 
summarised in Fig 9. 272 
 273 
Intratubular germ cell neoplasia cells are thought to originate in fetal life from abnormally differentiated 274 
gonocytes [3,15]. This is supported by similarities in morphological, immunohistochemical and genetic 275 
profiles [3,16,17]. Intratubular germ cell neoplasia cells share expression of a variety of proteins that are 276 
involved in pluripotency and early germ cell fate, such as OCT4 [18-20], PLAP [9,21] and AP2γ [8]. As 277 
gonocytes differentiate into spermatogonia during fetal life these markers have been shown to be 278 
downregulated [3,6,7,20,22,23]. OCT4, AP2γ and PLAP are described as ‘classical’ markers of intratubular 279 
germ cell neoplasia cells in adulthood and persistence of expression of these proteins is routinely used for 280 
diagnostic purposes for patients at risk of, or with suspected, testicular germ cell cancer [11]. These markers 281 
are considered highly sensitive and specific for intratubular germ cell neoplasia cells. Whilst we found co-282 
expression of AP2γ and OCT4 in intratubular germ cell neoplasia cells with no cells expressing a single 283 
marker alone, there was heterogeneity in the co-expression of PLAP and OCT4 in intratubular germ cell 284 
neoplasia cells. Expression of OCT4 has been reported to be expressed by all intratubular germ cell neoplasia 285 
cells [19], whilst PLAP has been reported to be expressed in 83-99% of intratubular germ cell neoplasia cells 286 
[9]. The present co-localisation studies demonstrate that the majority of the cells expressing OCT4 also 287 
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express PLAP. Overall co-localisation was seen in 68% of cells in tubules with intratubular germ cell 288 
neoplasia. Both of these sub-populations are also present in the normal human fetal testis during the transition 289 
from gonocyte to spermatogonia. However, our co-localisation studies have demonstrated the presence of a 290 
sub-population of intratubular germ cell neoplasia cells with a protein expression profile distinct from the 291 
germ cells in the normal human fetal testis. This OCT4-/PLAP+ sub-population represented 18% of the total 292 
cells in tubules with intratubular germ cell neoplasia. PLAP is expressed in most of the germ cells in a first 293 
trimester fetal testis, but is rare by the start of the second trimester [23]. OCT4 is also present in most of the 294 
germ cells of the first trimester, but is downregulated later in gestation in comparison to PLAP [24]. This study 295 
has shown that an OCT4-/PLAP+ population can be identified in tubules with intratubular germ cell neoplasia, 296 
whilst our results confirm that PLAP is not expressed without co-expression of OCT4 in the normal human 297 
fetal testis [23]. As these cells do not occur as part of normal germ cell development they may represent 298 
impaired maturation of gonocytes with loss of OCT4 and retention of PLAP expression as a result of an 299 
altered germ cell niche. 300 
 301 
In addition to the proteins that are found in undifferentiated germ cells, intratubular germ cell neoplasia cells 302 
have also been reported to express proteins characteristic of differentiated germ cells such as VASA [25] and 303 
MAGEA4 [26]. These markers begin to be expressed in germ cells during fetal life in increasing proportions 304 
as the cells differentiate [24,26-28]. We have shown that the majority of intratubular germ cell neoplasia cells 305 
(based on the expression of OCT4 and/or PLAP) do not express the spermatogonial proteins MAGEA4 and 306 
VASA.  We have quantified the expression of these differentiated germ cell markers in putative intratubular 307 
germ cell neoplasia for the first time and shown that MAGEA4 is only expressed in 6% of OCT4 and/or 308 
PLAP-expressing cells and therefore is not a common phenotype for putative intratubular germ cell neoplasia 309 
cells. Heterogeneous expression of MAGEA4 in intratubular germ cell neoplasia has been described 310 
previously, however VASA expression was reported to be expressed in all intratubular germ cell neoplasia 311 
cells [3]. We found that VASA was expressed heterogeneously in a similar proportion of putative intratubular 312 
germ cell neoplasia cells as those expressing MAGEA4.  313 
 314 
Previous studies have indicated that differentiated germ cells (e.g. spermatogonia) may be present within 315 
intratubular germ cell neoplasia containing tubules [12,22]. Co-staining for OCT4 and VASA/MAGEA4 316 
identified cells that had an OCT4-/VASA+ phenotype [22]. These cells would be considered differentiated 317 
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germ cells rather than intratubular germ cell neoplasia cells. We have described similar populations in our 318 
samples, however triple co-localisation has demonstrated that some VASA or MAGEA4 expressing cells that 319 
do not express OCT4, express PLAP and therefore may not represent ‘normal’ spermatogonia. As a result it is 320 
likely that only cells expressing neither OCT4 nor PLAP may represent normally matured germ cells that have 321 
not undergone pre-invasive change. The OCT4-/VASA+/PLAP+ or OCT4-/MAGEA4+/PLAP+ populations may 322 
represent pre-invasive germ cells that have undergone a degree of maturation towards pre-spermatogonia (due 323 
to downregulation of OCT4 and expression of VASA/MAGEA4), alternatively they may represent pre-324 
sprematogonia that have aberrantly retained PLAP expression following the downregulation of OCT4. In order 325 
to determine whether these populations could represent intratubular germ cell neoplasia cells we investigated 326 
expression during the development of invasive disease. OCT4 (without MAGEA4) was expressed in all intra-327 
tubular and invasive seminomas, indicating that intratubular germ cell neoplasia cells with invasive potential 328 
express OCT4 and do not express MAGEA4. Therefore we conclude that the OCT4-/MAGEA4+/PLAP+ cells 329 
do not represent intratubular germ cell neoplasia cells with malignant potential and are more likely to be a 330 
separate population of abnormally differentiated germ cells that are present in intratubular germ cell neoplasia 331 
containing tubules.  332 
 333 
Uncontrolled proliferation of cells is a hallmark of invasive tumours [29]. Previous studies have demonstrated 334 
proliferation in intratubular germ cell neoplasia and overt testicular germ cell cancer [12,30-32], and a 335 
previous study has shown that Ki67 expression is found in intratubular germ cell neoplasia cells in 14/16 non-336 
seminomas and 14/17 seminomas, although the proportion of intratubular germ cell neoplasia cells that were 337 
proliferating was not quantified [31]. A detailed analysis of proliferation in the various intratubular germ cell 338 
neoplasia sub-populations in relation to the underlying tumour type has not previously been performed. 339 
Intratubular germ cell neoplasia cells have previously been reported to proliferate at a relatively high rate. In a 340 
study of sections taken from patients with testicular germ cell cancer, using Ki67 as a marker of proliferation, 341 
17.42% of intratubular germ cell neoplasia cells were found to be Ki67 positive [30]. Overall we found that 342 
8.1% of intratubular germ cell neoplasia cells were positive for Ki67, however we have shown that the 343 
proliferation rate is dependent on which intratubular germ cell neoplasia sub-population is investigated. We 344 
have shown that PLAP is not expressed in ~20% of intratubular germ cell neoplasia (OCT4+) cells and this 345 
may partially explain the differences seen between proliferation of intratubular germ cell neoplasia cells in the 346 
present study compared to previous studies which relied on PLAP expression to identify intratubular germ cell 347 
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neoplasia cells [12,30]. The OCT4+/MAGEA4+ (and also OCT4-/MAGEA4+, not shown) populations are less 348 
proliferative than those expressing OCT4+/MAGEA4- which provides further evidence supporting the view 349 
that the OCT4+/MAGEA4- cells have more invasive potential than those expressing a more mature phenotype. 350 
This hypothesis is supported by our finding of little or no expression of MAGEA4 in the OCT4+ seminoma 351 
cells of an invasive tumour. We therefore propose that the OCT4+/MAGEA4- population of intratubular germ 352 
cell neoplasia cells give rise to the invasive tumour, whilst the OCT4+/MAGEA4+ population has a lower 353 
capacity to progress to invasiveness and may represent germ cells that are arrested in the transition from 354 
gonocyte to spermatogonia and do not contribute to the invasive tumour. OCT4-/MAGEA4+ cells are 355 
occasionally seen within the seminomatous component but are likely to represent spermatogonia that have 356 
become enclosed in the invasive tumour.  357 
 358 
Differences in the proliferation of intratubular germ cell neoplasia cells have recently been investigated with 359 
respect to one of the key regulators of the mitosis-meiosis switch, DMRT1 [12]. This study demonstrated that 360 
intratubular germ cell neoplasia cells expressing DMRT1 were significantly less proliferative than those 361 
intratubular germ cell neoplasia cells that did not express DMRT1 and that progression from ‘early-stage’ 362 
(Ki67-) intratubular germ cell neoplasia cell to invasive disease (Ki67+) is associated with a down-regulation 363 
of DMRT1. In order to test the hypothesis that certain subpopulations of intratubular germ cell neoplasia cells 364 
display differences in invasive potential, future studies involving isolation of the different intratubular germ 365 
cell neoplasia sub-populations followed by germ cell transplantation or xenografting may be performed. 366 
 367 
The present study has demonstrated the presence of proliferating intratubular germ cell neoplasia cells in testis 368 
tissue from patients with pre-invasive disease, seminoma and non-seminoma with a higher rate of proliferation 369 
in the OCT4+/MAGEA4- population in pre-invasive samples compared to those with an invasive tumour 370 
(either seminoma or non-seminoma). The finding of higher rates of proliferation of intratubular germ cell 371 
neoplasia cells in pre-invasive disease compared to tumours samples might be considered surprising given 372 
previous reports of low rates of proliferation in pre-invasive intratubular germ cell neoplasia cells [12]. In 373 
adults with pre-invasive disease this may be explained by an increase in proliferation around the time of 374 
progression to invasive disease, however this would not explain the proliferation rate for intratubular germ cell 375 
neoplasia cells in the pre-invasive childhood patients in which it might be expected that these cells are 376 
relatively quiescent. However, we have demonstrated previously that a higher proportion of OCT4+ germ cells 377 
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in the second trimester human fetal testis are proliferating compared with the MAGEA4+ population and that 378 
the rates of proliferation in the present study are similar to those in the normal human fetal testis for each sub-379 
population [10], indicating that the proliferation in the germ cell sub-populations in children with pre-invasive 380 
disease may simply reflect the proliferation rates in the normal human fetal testis.  381 
In conclusion, we have described in detail the heterogeneity of germ cell protein expression in cells within 382 
intratubular germ cell neoplasia tubules. We have demonstrated sub-populations of OCT4- cells that do not 383 
correspond to an equivalent stage of normal human fetal germ cell differentiation, suggesting that these cells 384 
may have lost expression of proteins that may determine their malignant potential. We have also demonstrated 385 
that a more undifferentiated/pluripotent expression profile is associated with an increased proliferation rate 386 
compared with a differentiated phenotype. These results indicate that germ cells expressing an 387 
OCT4+/MAGEA4- phenotype are those that will ultimately lead to tumour formation. 388 
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Figure Legends 469 
Figure 1 - Expression of gonocyte markers (OCT4, AP2γ and PLAP; A-I) and spermatogonial markers 470 
(MAGEA4 and VASA; J-O) in human fetal testis, intratubular germ cell neoplasia containing tubules (Adult – 471 
intratubular germ cell neoplasia) and tubules from adult testis with active spermatogenesis (Adult – ‘Normal’). 472 
Gonocyte proteins are detected in human fetal germ cells and intratubular germ cell neoplasia cells, but are 473 
absent from the germ cells in tubules with apparently normal spermatogenesis; whilst spermatogonial proteins 474 
are expressed in germ cells in all tissue types. Human fetal samples are 14 (A,D), 16 (J) and 18 weeks (G,M) 475 
gestation. Scale bar = 50µm. 476 
 477 
Figure 2 - Representative image for expression of VASA (green) and AP2γ (red) in tubules from adult 478 
patients with testicular germ cell cancer. A) Tubule with apparently normal spermatogenesis: VASA is 479 
expressed in the germ cells with no expression of the intratubular germ cell neoplasia/gonocyte protein AP2γ. 480 
B) Tubule with abnormal spermatogenesis: VASA expression is seen in the presumptive spermatocytes 481 
towards the lumen (white arrowhead), however germ cells along the basement membrane express VASA 482 
(yellow arrowhead) or AP2γ (yellow arrow). A small proportion of cells co-express VASA and AP2γ (white 483 
arrow). C) Intratubular germ cell neoplasia tubule: The majority of cells express the intratubular germ cell 484 
neoplasia protein AP2γ (yellow arrow) with a small number of cells adjacent to the basement membrane 485 
expressing VASA (presumptive spermatogonia; pink arrow). A small number of germ cells expressing VASA 486 
are located towards the lumen (presumptive spermatocytes; white arrowhead). 487 
 488 
Figure 3 - Expression of OCT4 (red) and PLAP (green) in intratubular germ cell neoplasia containing tubules 489 
from men with testicular germ cell cancer (A,C) and in normal human fetal testis tissue (B). The majority of 490 
intratubular germ cell neoplasia cells co-express OCT4 and PLAP (A,C; yellow arrowheads). Occasional 491 
OCT4 positive intratubular germ cell neoplasia cells are negative for PLAP expression (A; white arrow). 492 
Similar sub-populations of OCT4+/PLAP- (B, white arrow) and OCT4+/PLAP+ (B, yellow arrowheads) cells 493 
are also identified in the human fetal testis. In tubules with intratubular germ cell neoplasia, occasional OCT4-494 
/PLAP+ cells are identified (C; yellow arrows), however no similar population is seen in the human fetal testis. 495 
Counterstain (DAPI; blue). 496 
 497 
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Figure 4 - Representative image for expression of OCT4 (red), VASA (A; blue), MAGEA4 (B; blue) and 498 
PLAP (green) in intratubular germ cell neoplasia containing tubules from patients with testicular germ cell 499 
cancer. A) VASA expression is demonstrated in putative ‘spermatogenic’ germ cells that are negative for 500 
intratubular germ cell neoplasia cell proteins PLAP and OCT4 (white arrow). A small proportion of the 501 
VASA+ cells that are negative for OCT4 express PLAP (white arrowhead). B) The majority of cells co-express 502 
OCT4 and PLAP without MAGEA4, other sub-populations are identified including PLAP+/OCT4+/MAGEA4+ 503 
(pink arrow) and PLAP+/OCT4-/MAGEA4- (pink arrowhead). Counterstain (DAPI; pale blue) in merged 504 
panels. 505 
 506 
Figure 5 - Quantification of putative intratubular germ cell neoplasia phenotypes. Expression (+) of OCT4, 507 
PLAP and MAGEA4 for intratubular germ cell neoplasia containing tubules (n=9; pre-invasive, seminoma and 508 
non-seminoma; n=3 each). Bars with different letters are significantly different from each other (p<0.05). 509 
Mean +/- SEM.  510 
 511 
Figure 6 - Proliferation in putative intratubular germ cell neoplasia cells. A) Overall proliferation in all 512 
intratubular germ cell neoplasia cells. B) Proliferation (Ki67+) of intratubular germ cell neoplasia (OCT4+) 513 
cells based on the co-expression with MAGEA4 in tubules from all patients (B), children with pre-invasive 514 
disease (C; Pre-Inv. Child; n=4), adults with pre-invasive disease (D; Pre-Inv. Adult; n=6), seminoma (n=7) 515 
and non-seminoma (n=8). Mean +/- SEM. * p<0.05, ** p<0.01, **** p<0.0001. 516 
 517 
Figure 7 - Proliferation of intratubular germ cell neoplasia cells based on diagnosis of pre-invasive disease 518 
(PRE INV; n=7), seminoma (SEM; n=7) or non-seminoma (NON-SEM; n=8). A) Proliferation of OCT4+ 519 
intratubular germ cell neoplasia cells. B) Proliferation of OCT4+/MAGEA4+ intratubular germ cell neoplasia 520 
cells. Mean +/- SEM. * p<0.05, ** p<0.01, in comparison with pre-invasive intratubular germ cell neoplasia. 521 
 522 
Figure 8 - Representative images for expression of OCT4 (red), PLAP (green) and MAGEA4 (blue) in testis 523 
sections from patients with A) Intra-tubular seminoma, B) Seminoma with surrounding ‘normal’ (*) tubules 524 
and C) Seminoma. Note the lack of expression of MAGEA4 in both intra-tubular seminoma and invasive 525 
seminoma. Counterstain (DAPI; pale blue) in merged panels (bottom right). 526 
 527 
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Figure 9 - Schematic for germ cell maturation and proliferation in germ cells during transition from 528 
gonocyte to intratubular germ cell neoplasia and testicular germ cell cancer (bottom). Germ cell maturation 529 
from gonocyte to initiation of spermatogenesis is represented in the testis during the different stages of life 530 
(middle). For comparison, germ cell differentiation in the normal testis is also shown (top). Germ cells in the 531 
fetal testis may exhibit delayed maturation with persistence of gonocyte markers through childhood. A 532 
variety of germ cell protein profiles are present in the intratubular germ cell neoplasia tubule, however it is 533 
the cells expressing exclusively gonocyte proteins (with no spermatogonial proteins) that are more 534 
proliferative and contribute to the majority of the cells in intratubular seminoma and subsequently invasive 535 
seminoma. Cells expressing spermatogonial proteins are occasionally seen in the tubule or resultant tumour 536 
but exhibit low proliferation rates. Expression of OCT4 (red), PLAP (green) and MAGEA4 (blue) is shown 537 
for individual cells and cells with high rates of proliferation are indicated (yellow asterisk).538 
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Supplementary Figures 539 
Figure S1 540 
Expression of OCT4 (red) and VASA (green) in a seminiferous cord from a 14 week gestation human fetal 541 
testis. Sub-populations of gonocytes (OCT4+/VASA-; white arrowhead), pre-spermatogonia (OCT4+/VASA+; 542 
white arrow) and spermatogonia (OCT4-/VASA+; yellow arrowhead) are present within the tubule. 543 
 544 
Figure S2 545 
Representative image for expression of AP2γ (B; green) and OCT4 (C; red) in an intratubular germ cell 546 
neoplasia containing tubule from patients with testicular germ cell cancer. Intratubular germ cell neoplasia 547 
cells co-express both proteins in all cells (D; yellow). Nuclear counterstain with DAPI (A; blue). 548 
 549 
Figure S3 550 
Proportion of putative intratubular germ cell neoplasia cells expressing MAGEA4 in pre-invasive disease in 551 
childhood (PRE-INV. Child; n=4) and adulthood (PRE-INV. Adult; n=6), seminoma (SEM; n=9) and non-552 
seminoma (NON-SEM; n=8). Mean +/- SEM.   553 
 554 
Figure S4 555 
Example of triple immunofluorescence used for quantification of proliferation in sub-populations of 556 
intratubular germ cell neoplasia cells. Expression of Ki67 (green), OCT4 (red) and MAGEA4 (blue) in 557 
tubules containing intratubular germ cell neoplasia from a patient with testicular germ cell cancer. 558 
Arrowheads indicate proliferating OCT4+/MAGEA4- intratubular germ cell neoplasia cells, whilst the arrow 559 
indicates a proliferating OCT4+/MAGEA4+ intratubular germ cell neoplasia cell. 560 
 561 
Figure S5 562 
Proliferation (Ki67+) in MAGEA4 expressing intratubular germ cell neoplasia (OCT4+) cells in children with 563 
pre-invasive disease (C; Pre-Inv. Child; n=4), adults with pre-invasive disease (D; Pre-Inv. Adult; n=6), 564 
seminoma (n=7) and non-seminoma (n=8). Mean +/- SEM.  565 
 566 
Figure S6 567 
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Representative image of Ki67 (green), OCT4 (red) and MAGEA4 (blue) expression in seminoma (n=9). 568 
Seminoma cells express OCT4 (but not MAGEA4) and a large proportion also express Ki67, whilst the 569 
OCT4+ intratubular germ cell neoplasia cells (*) are less proliferative. MAGEA4+ cells are present in 570 
adjacent tubules (#) and are Ki67-. MAGEA4+/OCT4- cells are occasionally seen interspersed between the 571 
seminoma cells (arrow; inset). Counterstain (DAPI; pale blue) in merged panel (bottom right). 572 
 573 
 574 
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Table 1. Clinical characteristics of patients from whom tissue was obtained 
 
 
   
  1 0.8 Maturation delay, intra-abdominal testis  
  2  1 Maturation delay, intra-abdominal testis  
  3  7 Intratubular germ cell neoplasia, intra-abdominal testis 
  4  12 Intratubular germ cell neoplasia   
  5 21 Intratubular germ cell neoplasia only 
  6  31 Intratubular germ cell neoplasia, atrophy 
  7  34 Intratubular germ cell neoplasia only 
  8  36 Intratubular germ cell neoplasia only 
  9  36 Intratubular germ cell neoplasia only 
 10  32 Intratubular germ cell neoplasia, intra-tubular seminoma 
 
 11 Adult Seminoma 
 12  Adult Seminoma 
 13  Adult Seminoma 
 14  Adult Seminoma 
 15  Adult Seminoma 
 16  Adult Seminoma 
 17  Adult Seminoma 
 18  Adult Seminoma 
 19  Adult Seminoma 
 
 20 Adult Embryonal carcinoma with teratoma 
 21  Adult Mixed- embryonal carcinoma, teratoma and seminoma 
 22  Adult Embryonal carcinoma with teratoma 
 23  Adult Embryonal carcinoma with teratoma 
 24  Adult Mixed- embryonal carcinoma, yolk sac tumour, teratoma and seminoma                               
 25  Adult Embryonal carcinoma with teratoma 
 26  Adult Teratoma 
 27  Adult Teratoma 
 
 
Sample Age (y) Diagnosis
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Table 2. Antibodies and conditions for immunohistochemistry. All antibodies were raised against 
human peptide sequences 
 
 
 
 
 
 
 
 
 
 
 
a Santa Cruz Biotechnology, CA, USA 
b Abcam, Cambridge, UK. 
c Dr. Guilio Spagoli, University Hospital, Basel, Switzerland 
d Dako, Ely, UK 
 
Antigen Retrieval Source Species           Dilution
DAB          Fluorescence 
AP-2γ Y Santa Cruza Mouse 1:20 1:60
OCT 4 Y Santa Cruza Goat 1:50 1:150
PLAP Y Abcamb Rabbit 1:100 1:200
VASA Y Abcamb Rabbit 1:200 1:500
MAGEA4 N Giftc Mouse 1:20 1:100
Ki67 Y Dakod Rabbit 1:40 1:100
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